Rapt Therapeutics Other Long Term Liabilities (Quarterly) Insights

Rapt Therapeutics, Inc. (RAPT)

34.73 +0.67 (+1.97%) USD | NASDAQ | Jan 14, 16:00

34.81 +0.08 (+0.23%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Replimune Group, Inc.	Upgrade
Olema Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	Upgrade